Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-007732
Filing Date
2025-02-25
Accepted
2025-02-25 16:19:11
Documents
171
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 mrk-20241231.htm   iXBRL 10-K 5027463
2 EX-4.11 DESCRIPTION OF SECURITIES exh411-descriptionofsecuri.htm EX-4.11 261121
3 EX-10.1 EXECUTIVE INCENTIVE PLAN exh101-eipplan.htm EX-10.1 52585
4 EX-10.13 MERCK & CO., INC. U.S. SEPARATION BENEFITS PLAN exh1013-mrkseparationplan2.htm EX-10.13 1878617
5 EX-10.31 2024 ANNUAL RSU TERMS & CONDITIONS exh1031-2024annualrsuterms.htm EX-10.31 377195
6 EX-10.32 2024 ANNUAL PSU TERMS & CONDITIONS exh1032-2024annualpsuterms.htm EX-10.32 544084
7 EX-10.33 2024 ANNUAL NQSO TERMS & CONDITIONS exh1033-2024annualnqsoterm.htm EX-10.33 186652
8 EX-10.34 2024 SPECIAL RETENTION RSU TERMS & CONDITIONS exh1034-2024specialretenti.htm EX-10.34 83970
9 EX-10.35 OFFER LETTER (LARSON) exh1035-bettylarsonofferle.htm EX-10.35 64381
10 EX-10.36 2024 ANNUAL RSU SIGN-ON TERMS & CONDITIONS (LARSON) exh1036-2024annualrsusignx.htm EX-10.36 87452
11 EX-19 INSIDER TRADING POLICY exh19-insidertradingpolicy.htm EX-19 22558
12 EX-21 SUBSIDIARY LIST exh21-subsidiarylistasof12.htm EX-21 276395
13 EX-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exh23-consentofindependent.htm EX-23 2323
14 EX-24.1 POWER OF ATTORNEY exh241-powerofattorney.htm EX-24.1 15205
15 EX-24.2 CERTIFICATION OF BOARD RESOLUTION exh242-certificationofboar.htm EX-24.2 6759
16 EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO exh311-rule13ax14a15dx14ac.htm EX-31.1 8068
17 EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO exh312-rule13ax14a15dx14ac.htm EX-31.2 8103
18 EX-32.1 SECTION 1350 CERTIFICATION OF CEO exh321-section1350certific.htm EX-32.1 4057
19 EX-32.2 SECTION 1350 CERTIFICATION OF CFO exh322-section1350certific.htm EX-32.2 3662
25 exhibitcover.jpg GRAPHIC 348105
26 image_10.jpg GRAPHIC 3105
27 image_6.jpg GRAPHIC 34787
28 image_8x1.jpg GRAPHIC 7990
29 image_9.jpg GRAPHIC 6136
30 logo.jpg GRAPHIC 6373
31 mrk-20241231_g1.jpg GRAPHIC 137767
32 mrk-20241231_g2.jpg GRAPHIC 81788
33 mrk-20241231_g3.jpg GRAPHIC 28639
34 mrk-20241231_g4.jpg GRAPHIC 24577
35 mrk-20241231_g5.jpg GRAPHIC 24326
36 mrk-20241231_g6.jpg GRAPHIC 26041
37 mrk-20241231_g7.gif GRAPHIC 5605
38 mrk-20241231_g8.jpg GRAPHIC 31485
39 mrk-20241231_g9.jpg GRAPHIC 17845
40 picture1.jpg GRAPHIC 4032
  Complete submission text file 0001628280-25-007732.txt   31592793

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20241231.xsd EX-101.SCH 130598
21 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrk-20241231_cal.xml EX-101.CAL 161739
22 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20241231_def.xml EX-101.DEF 878153
23 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20241231_lab.xml EX-101.LAB 1483678
24 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20241231_pre.xml EX-101.PRE 1216944
174 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20241231_htm.xml XML 5843465
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 25663539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)